Strategic Evidence & Value Communication Symposium
Join us on 2021 年 4 月 21 日, 星期三, from12:00 PM – 2:00 PM EDT for Certara’s…
Certara2021 年 3 月 26 日
Purity is a Virtue: A Practical Guide to the Reporting of Impurities
Many pharmaceutical companies struggle with characterizing drug substance (DS) and drug product (DP) impurities and…
Certara2021 年 3 月 23 日
IQ WG Evaluation of PBPK Models for Organ-Impaired Populations
• The predictive performance of physiologically based pharmacokinetic(s) (PBPK) models for PK in renal impairment…
Certara2021 年 3 月 10 日
Sealing Pharma Commercialization Deals: Creating Optimal Value for Investors
It is crucial for biotech developers to engage in early commercial market assessment to generate…
Certara2021 年 3 月 5 日
Quantitative Systems Pharmacology for Drug Discovery and Development
Certara's Dr. Piet van der Graaf, Senior Vice President, Professor of Systems Pharmacology, Leiden University,…
Certara2021 年 3 月 2 日
RAPS Sponsored Webinar: Efficiency and Technology Pave the Way for the New Age of Narrative Writing
医学叙述是医学写作的核心组成部分。Sponsors sometimes need to prepare large…
Certara2021 年 2 月 8 日
How drug developers can avoid these common mistakes to secure a deal
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Certara2021 年 1 月 21 日
Making your biotech program investor-ready
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Certara2021 年 1 月 21 日
An Introduction to Asset Evaluation for Emerging Biotech Companies
Emerging biotech companies sometimes lack all of the experience, expertise, or financial capital to successfully…
Certara2021 年 1 月 21 日
Mechanistic model-informed discovery & development of bispecific antibodies for immuno-oncology: It takes 2 to tango
More than 50 bispecific antibodies are in oncology clinical development with a large diversity in…
Certara2020 年 12 月 2 日
